Osage University Partners IV, LP
Late investment period: first sale Apr 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $195.82M to $275M (Form D)
- Stages
- Pre-seed, Seed, Series A, Series B, Growth
- Sectors
- Biotech, Medical devices, Life sciences and research tools, Hardware, Climate software
- Regions
- Global
01 · Thesis
OUP invests in science-driven startups emerging from breakthrough research at leading labs and university partners. Focus areas include tech such as software, hardware, and climate tech, plus life science such as therapeutics, medtech, diagnostics, and research tools, at all stages from pre-seed through crossover.Inferred from the firm's website
02 · Initial check
$1.31M to $3.44M (estimated from fund size)
Estimated from Form D: $195.82M sold of a $275M target
03 · Who to approach
Named on this fund's Form D
- Robert Adelson, Managing Member of the General Partner
- Matt Cohen, Managing Partner
- Marc Singer, Managing Member of the General Partner
- Bill Harrington, Managing Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideOUP is currently investing out of its fourth fund, launched in 2023. The fund invests in science-driven startups emerging from breakthrough research.
we are currently investing out of our fourth fund launched in 2023
https://oup.vc/approach/
06 · Sources
Last verified: Oct 28, 2026